CHICAGO, May 26 /PRNewswire/ -- ProCure Treatment Centers, Inc., (ProCure) has selected Elekta to provide workflow enhancing software and treatment planning systems for its second IBA-equipped proton therapy center, which is under construction in suburban Chicago. ProCure collaborates with radiation oncology practices and hospitals to build and operate proton therapy centers.
Supporting the entire workflow, the solutions - which include the image-enabled oncology information system (OIS), MOSAIQ(R), as well as XiO(R) treatment planning system - will enable the facility to treat patients in a chartless, paperless environment.
Workflow optimization achieved through centralized information management
In clinical use at four proton therapy facilities worldwide, MOSAIQ provides centers with a sophisticated treatment management solution that streamlines radiation therapy planning, setup, verification, delivery review and analysis.
"With MOSAIQ, Elekta brings significant proton therapy and radiation oncology expertise," says Niek Schreuder, Senior Vice President of Medical Physics and Technology at ProCure Treatment Centers. "More importantly, Elekta shares ProCure's vision of making the OIS the central hub of the entire therapy workflow."
Site to benefit from quick, accurate treatment plans
A comprehensive treatment planning system that combines the latest tools and most robust dose calculation algorithms, XiO allows users to generate quick and accurate treatment plans. Developed more than a decade ago, XiO for protons is in clinical use at more proton facilities than any other commercial vendor. Vendor-neutral, XiO also is used in conjunction with IBA, Varian and Mitsubishi delivery systems.
"Because of their proven track record, ease of use and commitment to future enhancements, ProCure selected the Elekta systems for our suburban Chicago facility," adds Schreuder. "We're very pleased with the MOSAIQ and XiO systems currently installed in our Training and Development Center, as well as our soon-to-be opened Oklahoma center and we look forward to a continued relationship with Elekta."
"With a shared vision to deliver clinical advances for improved patient care, Elekta is delighted and proud to continue working with ProCure," says Stewart Pegrum, Particle Therapy Business Unit Manager for Elekta.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated state of the art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.
Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible today.
Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.
Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, visit elekta.com.
About ProCure Treatment Centers, Inc.
ProCure Treatment Centers, Inc., based in Bloomington, Ind., was founded in 2005 to improve the lives of patients with cancer by increasing access to proton therapy. ProCure collaborates with leading radiation oncology practices and hospitals and provides management leadership and a comprehensive approach for the design, construction, financing, staffing, training and day-to-day operations of world-class proton therapy centers. ProCure's solution reduces the time, cost and effort necessary to create a facility. ProCure is the only company in the world with two proton therapy centers under construction and two others in development. ProCure's Training and Development Center is the first facility in the world dedicated to proton therapy. For more information, visit www.ProCure.com.
Copyright©2009 PR Newswire.
All rights reserved